• FAQ
  • Sitemap
  • Legal Notices
  • Contacts
  • Hrv
  • About HALMED
  • Medicinal Products
  • Medical Devices
  • Distribution, Manufacturing and Inspection
  • Pharmacovigilance
  • News and Educations

Pharmacovigilance

  • Homepage
  • Pharmacovigilance
  • New Safety Information

Direct healthcare professional communication on the correct method of administration of Reseligo 3.6 mg and 10.8 mg implant in pre-filled syringe (goserelin)

30.08.2016

more

Direct healthcare professional communication on the non-interchangeability of Noxafil (posaconazole) tablet and oral suspension

24.08.2016

more

Meeting highlights from the CMDh meeting in July 2016

10.08.2016

more

CHMP confirms recommendations for use of Zydelig

26.07.2016

more

Meeting highlights from the CHMP meeting in July 2016

26.07.2016

more

Direct healthcare professional communication on the new list of compatible appliances for blood glucose determination in patients treated with Extraneal solution for peritoneal dialysis (icodextrin)

15.07.2016

more

PRAC concludes review of Zydelig and issues updated recommendations for use

11.07.2016

more

Review of factor VIII medicines and risk of developing inhibitors in patients starting treatment for haemophilia A

11.07.2016

more

EMA starts review of retinoid medicines

11.07.2016

more

EMA to review modified- and prolonged-release paracetamol

11.07.2016

more

  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • »

For Patients and Public

For Health Care Professionals

For Industry Representatives

  • What is Pharmacovigilance?
  • How to Report an Adverse Drug Reaction
  • New Safety Information
    • Archive 2022
    • Archive 2021
    • Archive 2020
    • Archive 2019
    • Archive 2018
    • Archive 2017
    • Archive 2016
    • Archive 2015
    • Archive 2014
    • Archive 2013
    • Archive 2012
    • Archive 2011
    • Archive 2010
    • Archive 2009
  • Direct Healthcare Professional Communication
  • Risk minimisation measures (RMM)
  • List of serious adverse reactions
  • Information for Marketing Authorisation Holders
  • Adverse Drug Reactions Reports
  • Pandemic Influenza A/H1N1
  • Information for Marketing Authorisation Holders - Electronic Transmission of ICSRs
  • Seal for Marking of Important Safety Information
  • Pharmacovigilance and Risk Assessment Committee (PRAC) - Links
  • Medicinal Products under Additional Monitoring
  • Signal management
  • Submission of Application Documentation for Assessment of Non-Interventional Trials
  • SCOPE Project
  • Access to Databases of Suspected ADRs
  • Homepage
  • FAQ
  • Sitemap
  • Legal Notices
  • Contacts
  • About HALMED
  • Medicinal Products
  • Medical Devices
  • Distribution, Manufacturing and Inspection
  • Pharmacovigilance
  • News and Educations
  • HALMED for:
  • Patients and Public
  • Health Care Professionals
  • Industry Representatives

Copyright © 2007-2025. Agency for Medicinal Products and Medical Devices of Croatia.
All rights reserved.